Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations.

PubWeight™: 4.32‹?› | Rank: Top 1%

🔗 View Article (PMID 20471072)

Published in Cell on May 13, 2010

Authors

Christopher J Lengner1, Alexander A Gimelbrant, Jennifer A Erwin, Albert Wu Cheng, Matthew G Guenther, G Grant Welstead, Raaji Alagappan, Garrett M Frampton, Ping Xu, Julien Muffat, Sandro Santagata, Doug Powers, C Brent Barrett, Richard A Young, Jeannie T Lee, Rudolf Jaenisch, Maisam Mitalipova

Author Affiliations

1: Whitehead Institute for Biomedical Sciences, 9 Cambridge Center, Cambridge, MA 02142, USA.

Articles citing this

(truncated to the top 100)

Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol (2011) 11.76

Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell (2011) 8.21

Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell (2011) 6.56

Derivation of novel human ground state naive pluripotent stem cells. Nature (2013) 5.90

Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell (2010) 5.13

Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci U S A (2010) 5.00

Induced pluripotency: history, mechanisms, and applications. Genes Dev (2010) 4.89

Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell (2010) 4.59

5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat Neurosci (2011) 4.15

Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell (2012) 2.94

Progress in understanding reprogramming to the induced pluripotent state. Nat Rev Genet (2011) 2.81

Systematic identification of culture conditions for induction and maintenance of naive human pluripotency. Cell Stem Cell (2014) 2.68

Female human iPSCs retain an inactive X chromosome. Cell Stem Cell (2010) 2.59

Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell (2012) 2.42

Gene silencing in X-chromosome inactivation: advances in understanding facultative heterochromatin formation. Nat Rev Genet (2011) 2.39

Mechanisms and models of somatic cell reprogramming. Nat Rev Genet (2013) 2.09

Derivation of naive human embryonic stem cells. Proc Natl Acad Sci U S A (2014) 2.04

DNA methylation dynamics in human induced pluripotent stem cells over time. PLoS Genet (2011) 2.00

Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell (2010) 1.81

Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell (2013) 1.80

Epigenetics of reprogramming to induced pluripotency. Cell (2013) 1.73

Efficient derivation of microglia-like cells from human pluripotent stem cells. Nat Med (2016) 1.64

Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. Proc Natl Acad Sci U S A (2011) 1.63

Enhancing Hematopoietic Stem Cell Transplantation Efficacy by Mitigating Oxygen Shock. Cell (2015) 1.51

Tracking the progression of the human inner cell mass during embryonic stem cell derivation. Nat Biotechnol (2012) 1.45

Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape. Cell Res (2011) 1.41

Genetic and epigenetic stability of human pluripotent stem cells. Nat Rev Genet (2012) 1.38

Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells. Cell Stem Cell (2012) 1.35

Human pluripotent stem cells: applications and challenges in neurological diseases. Front Physiol (2012) 1.31

Cancer-associated TERT promoter mutations abrogate telomerase silencing. Elife (2015) 1.28

Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression. Nature (2016) 1.25

Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes. Cell Stem Cell (2012) 1.23

The liberation of embryonic stem cells. PLoS Genet (2011) 1.20

Signaling defects in iPSC-derived fragile X premutation neurons. Hum Mol Genet (2012) 1.19

Toward eliminating HLA class I expression to generate universal cells from allogeneic donors. Blood (2013) 1.17

The transcriptional regulation of pluripotency. Cell Res (2012) 1.15

Alternative splicing produces Nanog protein variants with different capacities for self-renewal and pluripotency in embryonic stem cells. J Biol Chem (2011) 1.15

X-inactivation and X-reactivation: epigenetic hallmarks of mammalian reproduction and pluripotent stem cells. Hum Genet (2011) 1.14

Variations of X chromosome inactivation occur in early passages of female human embryonic stem cells. PLoS One (2010) 1.13

Accessing naïve human pluripotency. Curr Opin Genet Dev (2012) 1.13

Stem cells and reprogramming: breaking the epigenetic barrier? Trends Pharmacol Sci (2011) 1.12

Guidelines for the use of cell lines in biomedical research. Br J Cancer (2014) 1.11

Leukemia inhibitory factor (LIF)-dependent, pluripotent stem cells established from inner cell mass of porcine embryos. J Biol Chem (2011) 1.05

Mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations. PLoS One (2011) 1.04

X-chromosome inactivation: molecular mechanisms from the human perspective. Hum Genet (2011) 1.03

Inducing iPSCs to escape the dish. Cell Stem Cell (2011) 1.03

Derivation of new human embryonic stem cell lines reveals rapid epigenetic progression in vitro that can be prevented by chemical modification of chromatin. Hum Mol Genet (2011) 1.02

Hypoxia induces re-entry of committed cells into pluripotency. Stem Cells (2013) 1.01

Suppression of the imprinted gene NNAT and X-chromosome gene activation in isogenic human iPS cells. PLoS One (2011) 1.01

Environmental and epigenetic effects upon preimplantation embryo metabolism and development. Trends Endocrinol Metab (2011) 1.00

Female sex bias in human embryonic stem cell lines. Stem Cells Dev (2011) 0.99

Primed pluripotent cell lines derived from various embryonic origins and somatic cells in pig. PLoS One (2013) 0.99

Human intestinal tissue with adult stem cell properties derived from pluripotent stem cells. Stem Cell Reports (2014) 0.98

Reactivation of the inactive X chromosome in development and reprogramming. Cell Mol Life Sci (2012) 0.98

X-chromosome inactivation in rett syndrome human induced pluripotent stem cells. Front Psychiatry (2012) 0.97

Lineage-specific function of the noncoding Tsix RNA for Xist repression and Xi reactivation in mice. Genes Dev (2011) 0.96

X-chromosome epigenetic reprogramming in pluripotent stem cells via noncoding genes. Semin Cell Dev Biol (2011) 0.96

Oxygen levels that optimize TSC culture are identified by maximizing growth rates and minimizing stress. Placenta (2011) 0.95

X Chromosome of female cells shows dynamic changes in status during human somatic cell reprogramming. Stem Cell Reports (2014) 0.94

Concise review: Pluripotency and the transcriptional inactivation of the female Mammalian X chromosome. Stem Cells (2012) 0.94

Variable escape from X-chromosome inactivation: identifying factors that tip the scales towards expression. Bioessays (2014) 0.91

Feeder-free generation and long-term culture of human induced pluripotent stem cells using pericellular matrix of decidua derived mesenchymal cells. PLoS One (2013) 0.90

A prominent and conserved role for YY1 in Xist transcriptional activation. Nat Commun (2014) 0.90

Transcriptional and functional adaptations of human endothelial cells to physiological chronic low oxygen. Biol Reprod (2013) 0.89

Human embryonic stem cells derived from embryos at different stages of development share similar transcription profiles. PLoS One (2011) 0.89

Stable X chromosome reactivation in female human induced pluripotent stem cells. Stem Cell Reports (2015) 0.89

Chromatin features and the epigenetic regulation of pluripotency states in ESCs. Development (2014) 0.88

Establishment of LIF-dependent human iPS cells closely related to basic FGF-dependent authentic iPS cells. PLoS One (2012) 0.88

Power-laws and the use of pluripotent stem cell lines. PLoS One (2013) 0.88

Solving the "X" in embryos and stem cells. Stem Cells Dev (2012) 0.87

X chromosome inactivation: recent advances and a look forward. Curr Opin Genet Dev (2014) 0.86

Role of ATRX in chromatin structure and function: implications for chromosome instability and human disease. Reproduction (2011) 0.86

Rapid conversion of human ESCs into mouse ESC-like pluripotent state by optimizing culture conditions. Protein Cell (2012) 0.86

Transcriptional regulation in pluripotent stem cells by methyl CpG-binding protein 2 (MeCP2). Hum Mol Genet (2013) 0.86

Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity. Elife (2016) 0.85

Derivation of rhesus monkey parthenogenetic embryonic stem cells and its microRNA signature. PLoS One (2011) 0.85

Defining the role of oxygen tension in human neural progenitor fate. Stem Cell Reports (2014) 0.85

XCI in preimplantation mouse and human embryos: first there is remodelling…. Hum Genet (2011) 0.85

The evolving biology of small molecules: controlling cell fate and identity. Philos Trans R Soc Lond B Biol Sci (2011) 0.85

Mapping the networks for pluripotency. Philos Trans R Soc Lond B Biol Sci (2011) 0.84

X chromosome inactivation in human and mouse pluripotent stem cells. Hum Genet (2011) 0.84

Coupling of X-chromosome reactivation with the pluripotent stem cell state. RNA Biol (2014) 0.84

Embryonic stem cell-derived trophoblast differentiation: a comparative review of the biology, function, and signaling mechanisms. J Endocrinol (2013) 0.84

Diploid, but not haploid, human embryonic stem cells can be derived from microsurgically repaired tripronuclear human zygotes. Cell Cycle (2012) 0.84

Acute reduction in oxygen tension enhances the induction of neurons from human fibroblasts. J Neurosci Methods (2013) 0.83

Demarcation of stable subpopulations within the pluripotent hESC compartment. PLoS One (2013) 0.83

Continuous hypoxic culturing of human embryonic stem cells enhances SSEA-3 and MYC levels. PLoS One (2013) 0.83

HIF hits Wnt in the stem cell niche. Nat Cell Biol (2010) 0.83

Human Embryonic Stem Cells Do Not Change Their X Inactivation Status during Differentiation. Cell Rep (2016) 0.82

Comparative study of hematopoietic differentiation between human embryonic stem cell lines. PLoS One (2011) 0.82

Systematic optimization of human pluripotent stem cells media using Design of Experiments. Sci Rep (2015) 0.82

Single-Cell XIST Expression in Human Preimplantation Embryos and Newly Reprogrammed Female Induced Pluripotent Stem Cells. Stem Cells (2015) 0.82

Human X chromosome inactivation and reactivation: implications for cell reprogramming and disease. Philos Trans R Soc Lond B Biol Sci (2017) 0.81

Changes in sex ratio from fertilization to birth in assisted-reproductive-treatment cycles. Reprod Biol Endocrinol (2014) 0.81

CCL2 enhances pluripotency of human induced pluripotent stem cells by activating hypoxia related genes. Sci Rep (2014) 0.81

XACT Noncoding RNA Competes with XIST in the Control of X Chromosome Activity during Human Early Development. Cell Stem Cell (2016) 0.80

Regulation of X-chromosome dosage compensation in human: mechanisms and model systems. Philos Trans R Soc Lond B Biol Sci (2017) 0.80

Genetic and epigenetic X-chromosome variations in a parthenogenetic human embryonic stem cell line. J Assist Reprod Genet (2010) 0.80

Scope and impact of international research in human pluripotent stem cells. Stem Cell Rev (2012) 0.80

Enhanced cellular responses and distinct gene profiles in human fetoplacental artery endothelial cells under chronic low oxygen. Biol Reprod (2013) 0.80

Articles by these authors

Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature (2007) 65.18

A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell (2006) 48.80

Transcriptional regulatory networks in Saccharomyces cerevisiae. Science (2002) 43.52

Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature (2009) 35.48

Core transcriptional regulatory circuitry in human embryonic stem cells. Cell (2005) 34.93

Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature (2008) 30.29

In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature (2007) 28.24

Control of developmental regulators by Polycomb in human embryonic stem cells. Cell (2006) 28.21

Transcriptional regulatory code of a eukaryotic genome. Nature (2004) 27.21

Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature (2006) 25.90

One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell (2013) 24.00

A chromatin landmark and transcription initiation at most promoters in human cells. Cell (2007) 23.41

Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell (2007) 21.58

Dissecting direct reprogramming through integrative genomic analysis. Nature (2008) 16.47

Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell (2008) 16.38

Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A (2010) 15.13

Genome-wide map of nucleosome acetylation and methylation in yeast. Cell (2005) 15.08

Mediator and cohesin connect gene expression and chromatin architecture. Nature (2010) 14.34

BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell (2011) 14.34

Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science (2008) 13.79

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell (2009) 13.02

Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science (2007) 12.41

Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol (2009) 12.40

Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell (2008) 12.29

Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell (2008) 12.29

Control of pancreas and liver gene expression by HNF transcription factors. Science (2004) 12.05

Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity. Mol Cell (2003) 11.78

Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol (2011) 11.76

c-Myc regulates transcriptional pause release. Cell (2010) 11.64

Divergent transcription from active promoters. Science (2008) 11.03

Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell (2008) 10.68

E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev (2002) 10.06

Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell (2005) 9.84

RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo. Nat Genet (2007) 9.56

Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell (2013) 9.55

Cre-lox-regulated conditional RNA interference from transgenes. Proc Natl Acad Sci U S A (2004) 9.33

DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat Genet (2007) 9.25

HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell (2003) 9.12

Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol (2007) 9.04

Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med (2004) 8.89

Induction of tumors in mice by genomic hypomethylation. Science (2003) 8.86

Direct cell reprogramming is a stochastic process amenable to acceleration. Nature (2009) 8.71

Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Res (2005) 8.69

Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science (2003) 8.48

c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell (2007) 8.46

Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell (2013) 8.37

Transcriptional amplification in tumor cells with elevated c-Myc. Cell (2012) 8.24

YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol (2007) 8.11

One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell (2013) 7.99

Genome of the marsupial Monodelphis domestica reveals innovation in non-coding sequences. Nature (2007) 7.91

A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol (2008) 7.91

Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A (2008) 7.52

Super-enhancers in the control of cell identity and disease. Cell (2013) 7.50

Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell (2009) 7.39

Chromatin immunoprecipitation and microarray-based analysis of protein location. Nat Protoc (2006) 7.29

Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell (2012) 7.17

Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell (2011) 7.03

HDAC2 negatively regulates memory formation and synaptic plasticity. Nature (2009) 6.96

Genome-wide identification of polycomb-associated RNAs by RIP-seq. Mol Cell (2010) 6.88

NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A (2006) 6.80

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med (2012) 6.77

Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis (2006) 6.64

Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell (2011) 6.56

Computational discovery of gene modules and regulatory networks. Nat Biotechnol (2003) 6.55

Rapid analysis of the DNA-binding specificities of transcription factors with DNA microarrays. Nat Genet (2004) 6.33

Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci U S A (2005) 6.26

Chromosomal instability and tumors promoted by DNA hypomethylation. Science (2003) 6.02

Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature (2007) 5.81

Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science (2004) 5.64

Profiling critical cancer gene mutations in clinical tumor samples. PLoS One (2009) 5.63

Global and Hox-specific roles for the MLL1 methyltransferase. Proc Natl Acad Sci U S A (2005) 5.53

Chromosomal silencing and localization are mediated by different domains of Xist RNA. Nat Genet (2002) 5.51

Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell Stem Cell (2008) 5.40

Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell (2007) 5.29

Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell (2002) 5.19

X chromosome dosage compensation: how mammals keep the balance. Annu Rev Genet (2008) 5.18

Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci U S A (2002) 5.18

Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell (2010) 5.13

Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci U S A (2010) 5.00